Accelerated cTBS on Metabolic Dysfunction in People With Schizophrenia

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
cTBS is a promising novel intervention, which has strong potential on moderating disease syndrome. However, the most effective pattern of the cTBS is still under debate. Therefore, the investigators designed this randomized controlled clinical trial to evaluate the efficacy and safety of accelerated cTBS, with 1800 stimulation per session, on intervention to metabolic side effects in individuals with schizophrenia.
Epistemonikos ID: bef71b4a9ef6abbfa5a5dcbf59ab777540e03d50
First added on: Dec 20, 2022